13F Holdings
中文EN

CDIX Cardiff Lexington Corp

Services-Offices & Clinics of Doctors of Medicine · OTC · SEC CIK 811222 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.3%
TTM net income YoY-105.9%
TTM EPS YoY16.5%
Revenue 3-yr CAGR-1.8%
Net income 3-yr CAGR—

Margins

Gross margin60.4%
Operating margin-10.9%
Net margin-92.1%
FCF margin—
EBITDA margin-10.8%

Returns

ROE-749.4%
ROA-32.9%
ROIC (approx.)-4.7%
Asset turnover0.36x

Leverage & solvency

Liabilities / assets88.3%
Debt / equity12.95x
Current ratio0.91x
Interest coverage-0.14x

Cash quality & payout

Operating cash flow / net income0.17x
Accruals ratio-27.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.91M$2.16M$2.22M$2.77M$3.06M$2.79M$2.92M$3.12M
Cost of revenue$875,420$977,242$904,225$1.01M$1.15M$1.09M$1.08M$1.10M
Gross profit$1.04M$1.18M$1.32M$1.76M$1.91M$1.70M$1.84M$2.02M
SG&A expense$1.20M$1.36M$1.16M$1.84M$1.22M$987,319$1.28M$1.44M
Operating income-$536,666-$544,643-$511,159-$696,304$643,279$609,677$543,934$332,147
Interest expense$2.47M$2.14M$1.91M$2.23M$1.77M$1.84M$993,114$1.24M
Pretax income———-$2.92M-$1.14M-$1.23M-$450,777-$910,342
Net income-$3.21M-$2.48M-$3.09M-$2.69M-$1.14M-$1.23M-$450,777-$910,342
EBITDA-$536,433-$544,390-$510,566-$695,542$644,041$610,440$547,299$335,512
EPS (basic)-0.22-0.18-0.23—-0.21-0.24-0.14—
EPS (diluted)-0.22-0.18-0.23—-0.21-0.24-0.14—
Weighted avg. shares (diluted)15.72M15.27M14.52M—6.58M6.19M5.11M—
Balance sheet
Cash & equivalents$584,319$217,654$683,507$318,535$232,033$559,715$996,758$1.19M
Receivables$23.40M$23.73M$22.89M$22.07M$20.70M$19.19M$17.50M$15.93M
Current assets$24.22M$24.30M$23.86M$22.59M$21.04M$19.87M$18.61M$17.21M
PP&E, net$1,874$2,107$2,360$2,953$3,715$4,477$5,239$21,198
Goodwill$5.67M$5.67M$5.67M$5.67M$5.67M$5.67M$5.67M$5.67M
Total assets$30.58M$30.68M$30.29M$29.09M$27.61M$26.51M$25.33M$23.93M
Current liabilities$28.51M$26.61M$24.36M$25.83M$22.38M$20.29M$17.89M$15.89M
Short-term debt—————$0$0$3.62M
Long-term debt$25.03M$22.73M—$18.56M$15.07M$13.11M$10.70M$9.21M
Total debt$25.03M$22.73M—$18.56M$15.07M$13.11M$10.70M$12.83M
Total liabilities$28.99M$27.10M$24.63M$26.01M$22.60M$20.54M$18.23M$16.32M
Shareholders' equity-$283,512$1.76M$3.88M-$2.47M-$364,430$753,604$2.04M$2.69M
Net debt$24.44M$22.51M—$18.24M$14.84M$12.55M$9.71M$11.64M
Shares outstanding17.03M15.28M15.17M13.70M19.90M19.68M15.33M5.10M
Cash flow statement
Operating cash flow$432,674-$651,919-$16,730-$389,974-$574,297-$260,275-$491,420-$722,559
Financing cash flow-$66,009$186,066$381,702$476,476$246,615-$176,768$299,993-$38,856
Depreciation & amortization$233$253$593$762$762$763$3,365$3,365
Stock-based compensation$369,981$366,939$664,196$615,787$41,188$97,500$0$244,500
Dividends paid$0$0$0$0$0$0$50,000$0

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.